Skip to main content

Change location

You are currently on the Denmark (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Denmark (English)
  • Careers
  • Media and News
  • Get in touch
    • Denmark (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
      • X-Ray & CT
      • Contrast agents

        • Iomeron
      • Medical devices

        • CT Exprès
        • Protoco2l Touch
      • MRI
      • Contrast agents

        • Vueway (Gadopiclenol)
        • MultiHance
        • ProHance
      • Medical Devices

        • Empower MR
      • CEUS
      • Contrast agents

        • Sonovue
      • Software

        • VueBox
      • Molecular imaging
      • Radiopharmaceutical

        • CardioGen-82
      • Cardiovascular
      • Contrast agents

        • Iomeron
      • Medical devices

        • ACIST CVi
        • ACIST HDi
        • ACIST RXi
    • Digital health
    • Oncology
    • Cardiology
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
    • Education
    • Next-Gen Projects
    • Bracco Global Academy
    • Our Partnerships
    • Events
    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our stories
159 results found
Page
Cardiology Despite the availability of effective therapies, ischaemic heart disease remains the leading cause of death around the world. Early and proper diagnosis is key to reducing cardiovascular mortality and diagnostic imaging plays a crucial role here.
A surgeon preparing for surgery.
Page
Oncology According to the World Health Organization (WHO), in 2020 cancer accounted for nearly 10 million deaths worldwide – that’s almost one in every six deaths – with cancers of the lung, colon, and rectum, and prostate being the most common.
Laboratory researcher is looking through a microscope.
Article
Talking Images podcast: The sustainable way – voices of action Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?
sustainability podcast
Product
ProHance ProHance® is a macrocyclic, non-ionic gadolinium-based contrast agent, characterized by very low osmolality and viscosity.
Bracco logo
Product
CT Exprès A unique 3-channel syringeless contrast media CT scanner injector.
Bracco logo
Product
Iomeron Iomeron® is a non-ionic, monomeric, iodine contrast agent for radiology.
Bracco logo
Product
Protoco2l Touch PROTOCO2LTM is a unique system that fully automates the insufflation process, freeing staff for other duties.
Bracco logo
Product
MultiHance MultiHance® is a GBCA currently approved in the EU and Norway for use in diagnostic MRI of the liver in adult and in pediatric patients older than two years old.
Bracco logo
Product
Empower MR EmpowerMR® Contrast Injection System is a state-of-the-art integrated contrast injection system designed to meet the demands of today's advanced MR procedures.
Bracco logo
Product
Sonovue SonoVue® is an ultrasound contrast agent, designed and optimized for pressure resistance: this is the result of many years of research and development.
Bracco logo
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182